Extend (Pharmaceuticals and Biotechnology) Overview

  • Year Founded
  • 2021

Year Founded

  • Status
  • Private

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Joint Venture

  • Investors
  • 3

Extend (Pharmaceuticals and Biotechnology) General Information

Description

Operator of a therapeutic and entrepreneurial initiative intended to create new companies from academic research. The company' specializes in therapeutic areas with unmet medical needs, such as oncology, central nervous system, and rare diseases, using biotechnology-related options such as gene and cell therapy, and monoclonal antibodies, enabling universities, research cntres, and venture-building partners to market for the initiatives for the advancement of research in the biopharmaceutical sector for a variety of major medical problems.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Corporate Office
  • Via Alessandria 220
  • 00198 Rome
  • Italy
Primary Industry
Drug Discovery
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • Via Alessandria 220
  • 00198 Rome
  • Italy

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Extend (Pharmaceuticals and Biotechnology) Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Joint Venture 28-Oct-2022 Completed Generating Revenue
To view Extend (Pharmaceuticals and Biotechnology)’s complete valuation and funding history, request access »

Extend (Pharmaceuticals and Biotechnology) Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Extend (Pharmaceuticals and Biotechnology) Investors (3)

Investor Name Investor Type Holding Investor Since Participating Rounds
Angelini Ventures Corporate Venture Capital Minority
CDP Venture Capital (Rome) Venture Capital Minority
Evotec Corporation Minority
To view Extend (Pharmaceuticals and Biotechnology)’s complete investors history, request access »

Extend (Pharmaceuticals and Biotechnology) Investments (1)

Extend (Pharmaceuticals and Biotechnology)’s most recent deal was a Later Stage VC with Resilco for . The deal was made on 12-Mar-2025.

Company Name Deal Date Deal Type Deal Size Industry Lead Partner
Resilco 12-Mar-2025 Later Stage VC Environmental Services (B2B)
To view Extend (Pharmaceuticals and Biotechnology)’s complete investments history, request access »

Extend (Pharmaceuticals and Biotechnology) FAQs

  • When was Extend (Pharmaceuticals and Biotechnology) founded?

    Extend (Pharmaceuticals and Biotechnology) was founded in 2021.

  • Where is Extend (Pharmaceuticals and Biotechnology) headquartered?

    Extend (Pharmaceuticals and Biotechnology) is headquartered in Rome, Italy.

  • What is the size of Extend (Pharmaceuticals and Biotechnology)?

    Extend (Pharmaceuticals and Biotechnology) has 6 total employees.

  • What industry is Extend (Pharmaceuticals and Biotechnology) in?

    Extend (Pharmaceuticals and Biotechnology)’s primary industry is Drug Discovery.

  • Is Extend (Pharmaceuticals and Biotechnology) a private or public company?

    Extend (Pharmaceuticals and Biotechnology) is a Private company.

  • What is Extend (Pharmaceuticals and Biotechnology)’s current revenue?

    The current revenue for Extend (Pharmaceuticals and Biotechnology) is .

  • Who are Extend (Pharmaceuticals and Biotechnology)’s investors?

    Angelini Ventures, CDP Venture Capital (Rome), and Evotec have invested in Extend (Pharmaceuticals and Biotechnology).

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process